PAR 0.00% 30.0¢ paradigm biopharmaceuticals limited..

12 Month Data Release Pres - Q& A, page-22

  1. 353 Posts.
    lightbulb Created with Sketch. 399
    I would temper any lack of enthusiasm with we have not heard the 12 month data before last week, indicating reduced pain and increased function from one round of treatment out to an entire year!

    We have also not heard the 6 month MRI data that may likely show clear modification of the disease, which is already known to occur in animals that vets treat with it (its on their label).

    We have also not heard encouraging talk of China as a region they are confident in. At most I think it was mentioned in passing previously.

    This story has taken several years longer to play out than originally expected, but it's been moving forward the entire time and is seriously undervalued for a Stage 3 that has incredible evidence of long lasting impacts, a huge global market to tap into, a 25 supply exclusivity on a compound that is near impossible to reverse engineer.

    If this was a mining stock, let me put it this way.

    There is at a minimum $250B worth of rare unobtainium and a mine life of 25 years. They are going to make billions, hopefully eventually tens of billions each year hopfully starting 2025 all they way through to at least 2050.

    The market cap is currently on fifth of a billion...
    Last edited by PARdonthepun: 15/10/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $104.9M
Open High Low Value Volume
30.0¢ 31.0¢ 29.5¢ $89.62K 294.9K

Buyers (Bids)

No. Vol. Price($)
3 20607 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 16773 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.